The Effect of Leptin, Ghrelin and Estradiol Hormones on Insulin Resistance and Anthropometric Markers in Polycystic Ovary Syndrome Women Patients

Authors

  • Laveen Bakhtear Department of biology, Faculty of science & Health, Koya University, Koya KOY45, Kurdistan Region – F.R. Iraq
  • Ismail Salih Ibraheem Kakey Department of biology, Faculty of science & Health, Koya University, Koya KOY45, Kurdistan Region – F.R. Iraq

Abstract

Background: Patients with Polycystic ovary syndrome (PCOS) are more prone to abnormal production of some regulatory peptides. The importance of leptin in PCOS-related endocrine and metabolic disorders have been gradually recognized. This study aims to evaluate serum levels of leptin and ghrelin and their correlation with insulin resistance and anthropometric indices in PCOS.  Methods: This case-control study was conducted on 80 women;65 with PCOS and 15 healthy women whose age ranging from 17 to 37 years old and body mass index (BMI) were matched and who referred to Dr. Shahid Xalid Hospital, koya, Kurdistan. Serum levels of leptin, ghrelin, insulin, fast glucose   and estradiol were measured, Homeostatic Model Assessment for Insulin Resistance was calculated. Results: The results showed, that serum levels of leptin, insulin and fast glucose and estradiol were significantly higher (p, <0.05) while ghrelin were significantly lower in PCOS patients women compared with healthy. Serum level of leptin showed positive correlation with BMI (r= 0.85, p= 0.001), waist circumference (WC) (r= 0.55, p= 0.01), insulin resistance (r= 0.67, p= 0.01), while ghrelin level showed negative correlation with BMI, IR, WC. Conclusion: The results showed increased leptin level while ghrelin level was decreased in PCOS patients. leptin level was positively correlated with BMI, WC, IR, while ghrelin level was negatively correlated with BMI, WC and IR.

Downloads

Download data is not yet available.

References

Becker GF, Passos EP, Moulin C.C. (2015). Short-term effects of a hypocaloric diet with low glycemic index and low glycemic load on body adiposity, metabolic variables, ghrelin, leptin, and pregnancy rate in overweight and obese infertile women: a randomized controlled trial. Am J Clin Nutr. ;102(6):1365-1372.

Daghestani MH, Daghestani M, Daghistani M, El-Mazny A, Bjørklund G, Chirumbolo S, Al Saggaf SH, Warsy A. (2018). A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS). Lipids Health Dis. 21;17(1): 195.

Daghestani MH, El-Mazny A(2011). Circulating ghrelin levels and the polycystic ovary syndrome: correlation with the clinical, hormonal and metabolic features. Eur J Obstet Gynecol Reprod Biol. ;155:65–68.

Davinelli S, Nicolosi D, Di Cesare C, Scapagnini G, Di Marco R(2020). Targeting metabolic consequences of insulin resistance in polycystic ovary syndrome by D-chiro-inositol and emerging nutraceuticals. J Clin Med. 2;9(4):987.

Garin, M. C., Butts, S. F., Sarwer, D. B., Allison, K. C., Senapati, S., & Dokras, A. (2017). Ghrelin is independently associated with anti-mullerian hormone levels in obese but not non-obese women with polycystic ovary syndrome. Endocrine, 55(3), 907-913.

Houjeghani S, Pourghassem Gargari B, Farzadi L (2012). Serum leptin and ghrelin levels in women with polycystic ovary syndrome: correlation with anthropometric, metabolic, and endocrine parameters. Int J Fertil Steril. Jul;6(2):117-26.

Ibrahim, M.K. and Alobaidi, A.H., 2021. Evaluation of the role of ghrelin and leptin as biochemical markers in female with polycystic ovarian syndrome. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Inflammatory and Anti-Allergy Agents), 20(4), pp.373-379.

Lugilde J, Casado S, Beiroa D, Cuñarro J, Garcia-Lavandeira M, Álvarez CV, Nogueiras R, Diéguez C, Tovar S (2022). LEAP-2 Counteracts Ghrelin-Induced Food Intake in a Nutrient, Growth Hormone and Age Independent Manner. Cells. 19;11(3):324

Messinis, I.E., Messini, C.I., Anifandis, G. and Dafopoulos, K., 2015. Polycystic ovaries and obesity. Best Practice & Research Clinical Obstetrics & Gynaecology, 29(4), pp.479-488.

Mitkov, M., Pehlivanov, B. and Orbetzova, M., 2008. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters. Gynecological Endocrinology, 24(11), pp.625-630.

Mohamed, W.S., Hassanien, M. and Sayed Abokhosheim, K.E.L., 2014. Role of ghrelin, leptin and insulin resistance in development of metabolic syndrome in obese patients. Endocrinol Metab Synd, 3(122), pp.2161-1017.

Monteiro, M.P. and Batterham, R.L., 2017. The importance of the gastrointestinal tract in controlling food intake and regulating energy balance. Gastroenterology, 152(7), pp.1707-1717.

Orio F Jr, Lucidi P, Palomba S, Tauchmanova L, Cascella T, Russo T, Zullo F, Colao A, Lombardi G, De Feo P(2003). Circulating ghrelin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab;88(2):942-5.

Pehlivanov B, Mitkov M(2009). Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Eur J Contracept Reprod Health Care.;14(2):153-9.

Pektas, S.D., Cinar, N., Duman, D.D., Kara, A., Batu, J., Karakas-Celik, S. and Aksoy, D.Y., 2020. The relationship among androgens, insulin resistance and ghrelin polymorphisms in post-adolescent male patients with severe acne vulgaris. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 37(5), pp.800-809.

Peng Y, Yang H, Song J, Feng D, Na Z, Jiang H, Meng Y, Shi B, Li D(2022). Elevated Serum Leptin Levels as a Predictive Marker for Polycystic Ovary Syndrome. Front Endocrinol (Lausanne).:845165.

Polak, K., Czyzyk, A., Simoncini, T. and Meczekalski, B., 2017. New markers of insulin resistance in polycystic ovary syndrome. Journal of endocrinological investigation, 40, pp.1-8.

Rostamtabar, M., Esmaeilzadeh, S., Tourani, M., Rahmani, A., Baee, M., Shirafkan, F., Saleki, K., Mirzababayi, S.S., Ebrahimpour, S. and Nouri, H.R., 2021. Pathophysiological roles of chronic low‐grade inflammation mediators in polycystic ovary syndrome. Journal of cellular physiology, 236(2), pp.824-838.

Salehpour S, Taherzadeh Broujeni P, Neisani Samani E (2008). Leptin, ghrelin, adiponectin, homocysteine and insulin resistance related to polycystic ovary syndrome. Int J Fertil Steril;2(3):101–104.

Sato, T., Ida, T., Nakamura, Y., Shiimura, Y., Kangawa, K. and Kojima, M., 2014. Physiological roles of ghrelin on obesity. Obesity research & clinical practice, 8(5), pp.e405-e413.

Sengupta, P., Bhattacharya, K. and Dutta, S., 2019. Leptin and male reproduction. Asian Pacific Journal of Reproduction, 8(5), p.220.

Shorakae, S., Teede, H., de Courten, B., Lambert, G., Boyle, J. and Moran, L.J., 2015, July. The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome. In Seminars in reproductive medicine (Vol. 33, No. 04, pp. 257-269).

Sirmans, S.M. and Pate, K.A., 2013. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clinical epidemiology, pp.1-13.

Targher, G., Rossini, M. and Lonardo, A., 2016. Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?. Endocrine, 51, pp.211-221.

Downloads

Published

2024-06-30

How to Cite

Bakhtear, L., & Salih Ibraheem Kakey, I. . . (2024). The Effect of Leptin, Ghrelin and Estradiol Hormones on Insulin Resistance and Anthropometric Markers in Polycystic Ovary Syndrome Women Patients. Academic Journal of Nawroz University, 13(2), 834–839. Retrieved from https://journals.nawroz.edu.krd/index.php/ajnu/article/view/1693

Issue

Vol. 13 No. 2 (2024)

Section

Letters

License

Copyright (c) 2024 Academic Journal of Nawroz University

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors retain copyright

The use of a Creative Commons License enables authors/editors to retain copyright to their work. Publications can be reused and redistributed as long as the original author is correctly attributed.

 

  1. Copyright

 

  1. The researcher(s), whether a single or joint research paper, must sell and transfer to the publisher (the Academic Journal of Nawroz University) through all the duration of the publication which starts from the date of entering this Agreement into force, the exclusive rights of the research paper/article. These rights include the translation, reuse of papers/articles, transmit or distribute, or use the material or parts(s) contained therein to be published in scientific, academic, technical, professional journals or any other periodicals including any other works derived from them, all over the world, in English and Arabic, whether in print or in electronic edition of such journals and periodicals in all types of media or formats now or that may exist in the future. Rights also include giving license (or granting permission) to a third party to use the materials and any other works derived from them and publish them in such journals and periodicals all over the world. Transfer right under this Agreement includes the right to modify such materials to be used with computer systems and software, or to reproduce or publish it in e-formats and also to incorporate them into retrieval systems.

 

  1. Reproduction, reference, transmission, distribution or any other use of the content, or any parts of the subjects included in that content in any manner permitted by this Agreement, must be accompanied by mentioning the source which is (the Academic Journal of Nawroz University) and the publisher in addition to the title of the article, the name of the author (or co-authors), journal’s name, volume or issue, publisher's copyright, and publication year.

 

  1. The Academic Journal of Nawroz University reserves all rights to publish research papers/articles issued under a “Creative Commons License (CC BY-NC-ND 4.0) which permits unrestricted use, distribution, and reproduction of the paper/article by any means, provided that the original work is correctly cited.

 

  1. Reservation of Rights

The researcher(s) preserves all intellectual property rights (except for the one transferred to the publisher under this Agreement).

  1. Researcher’s guarantee

The researcher(s) hereby guarantees that the content of the paper/article is original. It has been submitted only to the Academic Journal of Nawroz University and has not been previously published by any other party.

In the event that the paper/article is written jointly with other researchers, the researcher guarantees that he/she has informed the other co-authors about the terms of this agreement, as well as obtaining their signature or written permission to sign on their behalf.

The author further guarantees:

  • The research paper/article does not contain any defamatory statements or illegal comments.
  • The research paper/article does not violate other's rights (including but not limited to copyright, patent, and trademark rights).

This research paper/article does not contain any facts or instructions that could cause damages or harm to others, and publishing it does not lead to disclosure of any confidential information.